KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medtronic (MDT) Tax Provisions (2016 - 2026)

Medtronic's Tax Provisions history spans 13 years, with the latest figure at $254.0 million for Q1 2026.

  • On a quarterly basis, Tax Provisions rose 7.17% to $254.0 million in Q1 2026 year-over-year; TTM through Jan 2026 was $923.0 million, a 1.28% decrease, with the full-year FY2025 number at $936.0 million, down 17.39% from a year prior.
  • Tax Provisions hit $254.0 million in Q1 2026 for Medtronic, up from $215.0 million in the prior quarter.
  • Over the last five years, Tax Provisions for MDT hit a ceiling of $959.0 million in Q4 2022 and a floor of $106.0 million in Q1 2022.
  • Historically, Tax Provisions has averaged $270.0 million across 5 years, with a median of $220.0 million in 2024.
  • Biggest five-year swings in Tax Provisions: skyrocketed 444.89% in 2022 and later tumbled 58.08% in 2023.
  • Tracing MDT's Tax Provisions over 5 years: stood at $959.0 million in 2022, then plummeted by 58.08% to $402.0 million in 2023, then tumbled by 30.1% to $281.0 million in 2024, then decreased by 23.49% to $215.0 million in 2025, then rose by 18.14% to $254.0 million in 2026.
  • Business Quant data shows Tax Provisions for MDT at $254.0 million in Q1 2026, $215.0 million in Q4 2025, and $255.0 million in Q3 2025.